Browse > Article

Controlled Release of Bordetella Bronchiseptica Dermonecrotoxin(BBD) Vaccine from BBD-Loaded Chitosan Microspheres In Vitro  

Jiang, Hu-Lin (School of Agricultural Biotechnology, Seoul National University)
Park, In-Kyu (School of Agricultural Biotechnology, Seoul National University)
Shin, Na-Ri (College of Veterinary Medicine and the School of Agricultural Biotechnology, Seoul National University)
Yoo, Han-Sang (College of Veterianry Medicine and the School of Agricultural Biotechnology, Seoul National University)
Akaike, Toshihiro (Department of Biomolecular Engineering, Tokyo Institute of Technolog)
Cho, Chong-Su (School of Agricultural Biotechnology, Seoul National University)
Publication Information
Archives of Pharmacal Research / v.27, no.3, 2004 , pp. 346-350 More about this Journal
Abstract
Chitosan microspheres were prepared by ionic gelation process with sodium sulfate for nasal vaccine delivery. Bordetella Bronchiseptica Dermonecrotoxin (BBD) as a major virulence factor of a causative agent of atrophic rhinitis (AR) was loaded to the chitosan microspheres for vaccination. Morphology of BBD-loaded chitosan microspheres was observed as spherical shapes. The average particle sizes of the BBD-loaded chitosan microspheres were about $2.69$\mid${\;}\mu\textrm{m}$. More BBD was released with an increase of molecular weight of chitosan and with an increase of medium pH in vitro due to weaker intermolecular interaction between chitosan and BBD. Tumor necrosis $factor-{\alpha}{\;}(TNF{\alpha})$ and nitric oxide (NO) from RAW264.7 cells stimulated with BBD-loaded chitosan microspheres were gradually secreted, suggesting that released BBD from chitosan microspheres had immune stimulating activity of AR vaccine.
Keywords
Chitosan microspheres; Bordetella Bronchiseptica Dermonecrotoxin; Nasal vaccine delivery; Tumor necrosis $factor-{\alpha}$; Nitric oxide;
Citations & Related Records

Times Cited By Web Of Science : 6  (Related Records In Web of Science)
Times Cited By SCOPUS : 7
연도 인용수 순위
1 Ilium, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A. N., and Davis, S. S., Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev., 51, 81-96 (2001)   DOI   ScienceOn
2 Janes, K. A., Calvo. P., and Alonso, M. J., Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev., 47, 83-97 (2001)   DOI   ScienceOn
3 Lowry, O. and Rosebrough, N., Protein measurement with the folin phenol reagent. J. Biol. Chem., 193-265 (1951)   PUBMED
4 Lydyard, P. and Grossi, C., The lymphoid system. Immunology, 5, 31-42 (1998)
5 Saiki, I., Murata, J., Tokura, S., and Azuma, I., Inhibition by sulfated chitin derivatives of advasion through extracellular matrix and enzymatic degradation metastatic melanoma cells. Cancer Res., 50, 3631-3637 (1990)   PUBMED
6 Shin, N. R., Kim, J. M., and Yoo, H. S., Korean J. Vet. Res., 40, 551-561 (2000)
7 Van der Lubben, I. M., Kersten, G., Fretz, M. M., Beuvery, C., Verhoef, J. C., and Junginger, H. E., Chitosan microparticles for mucosal vaccination against diphtheria:oral and nasal efficacy studies in mice. Vaccine, 21, 1400-1408 (2003)   DOI   ScienceOn
8 Mi, F. L., Shyu, S. S., Chen, C. T., and Schoung, J. Y., Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release, Biomaterials, 20, 1603-1612 (1999)   DOI   ScienceOn
9 Hasebe, H., Occurrence and epizootiological surveys of infectious atrophic rhinitis in swine. Nippon Vet. Zootech. Col. Bull., 19, 92-102 (1971)
10 Green, L. C., Wagner, D. A., Glogowski, J., Skipper, PL., J. Wishnok, S., and Tannenbaum, S. R., Analysis of nitrate, nitrite, and $[^{15}N]$ nitrate in biological fluids. Anal. Biochem., 126, 131-138 (1992)   DOI   ScienceOn
11 Kreuter, J. and Speiser, P. P., New adjutants on poly (methylmethacrylate) base. Infect Immunol., 13, 204-210 (1976)   PUBMED
12 He, P., Davis, S. S, and ilium, L., In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm., 166, 75-88 (1998)   DOI   ScienceOn
13 Kreuter, J., Liehl, E., and Berg, V., Influence of hydrophobicity on the adjuvant effect of particlate polymeric adjutants. Vaccine, 6, 253-256 (1988)   DOI   ScienceOn
14 Lika, I., Vine, T., Nishimura, K., and Azuma, I., Simulation of non-specific host resistance against Sendai virus and E. coli infection by chitin in mice. Vaccine, 5, 270-274 (1987)   DOI   ScienceOn
15 Artursson, P., Lindmark, T., Davis, S. S., and ilium, L., Effect of chitosan on permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res., 11, 1358-1361 (1994)   DOI
16 Suzuki, K., Ogawa, Y., Hashimoto, K., Suzuki, S., and Suzuki, M., Protecting elect of chitin and chitosan on experimentally induced murine candidasis. Microbial. Immunol., 28, 903-904 (1984)
17 Eldridge, J. H., Hammond, C. J., Meulbrock, J. A., Staas, J. K., Gilley, R. M., and Rice, T. R., Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches. J. Cont. ReI., 11, 205-214 (1990)   DOI   ScienceOn
18 Ilium, L., Farraj, N. F., and Davis, S. S., Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res., 11, 1186-1189 (1994)   DOI
19 Kreuter, J. and Speiser, .P P., In vitro studies of poly (methylmethacrylate) adjutants. J. Pharm. Sci., 65, 1624-1627 (1976)   DOI   PUBMED
20 Eyles, J., Sharp, G., Williamson, E., Spiers, I., and Alpar, H., Intranasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine, 16, 698-707 (1998)   DOI   ScienceOn
21 Kreuter, J. and Liehl, E., Long-term studies of microencapsulated and adsorbed influenza vaccine nanoparticles. J. Pharm. Sci., 70, 367-371 (1981)   DOI   PUBMED